EMA
approval
· 2012-01-20
European Medicines Agency recommends approval of new medicine for Cushing's disease
Summary
EMA recommends approval of a new medicine for Cushing's disease, indicating a potential new treatment option after evaluation.
Upgrade for the full analysis, importance score, and drug timeline.